Enter multiple symbols separated by commas

Trading The Globe: Is Beijing Telling The Truth?

The latest economic data out of China is due to be released on Friday and once again it’s expected to show impressive results. By all accounts industrial output should be improving and retail sales should be strong.

Just two more signs that China is quickly returning to solid economic health.

And other data furnished by Beijing earlier in the week suggests much the same – China is booming -- while the US and Europe continue to struggle.

In fact that bullish data accounts for the run up in the FXI as you can see from this chart.

No news in those tidbits, except maybe they're not true.

Major investors are starting to question whether Beijing is telling the truth. "I think the story is getting harder and harder to believe," says widely followed billionaire investor and hedge fund manager Jim Chanos.

"And I'm not the only guy crying about the data coming out of China. You are seeing a lot more articles being written about it, a lot more skeptical voices being heard about just how accurate some of this data showing this Chinese miracle. And the fact of the matter is I don't think it’s very accurate at all."

Considering the data may be questionable, is there a better 'tell."

Zach Karabell says there is. In fact he tells the desk, "I wouldn’t pay attention to government statistics as a reason to invest in China, ever."

Instead he makes bets on China using numbers that can't easily be manipulated "such as the price of copper or GM’s auto sales in China. Those figures are real indicators of demand," he says.

What do you think? We want to know!

To your left is the CNBC interview with Jim Chanos referenced above.

Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to fastmoney@cnbc.com.

Trader disclosure: On Sept. 10th, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Najarian Owns (AAPL) & Short (AAPL) Calls; Najarian Owns (BAC) & Short (BAC) Calls: Najarian OWns (C) Calls: Najarian Owns (FCX), Owns (FCX) Put, Is Short (FCX) Calls; Najarian Owns (JPM) & Is Short (JPM) Calls; Najarian Owns (JOYG) & Short (JOYG) Calls; Najarian Owns (MS) And Is Short (MS) Call; Najarian Owns (MSFT) And Is Short (MSFT) Call; Najarian Owns (MOS) Call Spread; Najarian Owns (PALM) Calls; Najarian Owns (RIMM) Call Spread; Najarian Owns (TEVA); Najarian Owns (V) & Short (V) Calls; Najarian Owns (YHOO) Calls; J Najarian Owns (AAPL), (BAC), (C), (BX), (ESLR), (GS), (GLW), (HGSI), (NUE), (PDE), (SUN), (WFC); Seymour Owns (AA), (AAPL), (BAC), (BX), (DRY), (EEM); Seymour's Firm Is Short (FXI), (F), (RIG); Karabell Owns (AAPL), (BHP), (C), (FCX), (FXI), (IBM), (JPM), (MON), (NOK), (HON)

For Charles Boorady
Citi has managed an offering of securities of (CI)
Citi has received compensation from (AET)
Citi has received compensation from (CI)
Citi has received compensation from (UNH)
Citi has has (CI) as a client in past 12 months
Citi has has (AET) as a client in past 12 months
Citi has has (HUM) as a client in past 12 months

For Joseph Greff
J.P. Morgan has an investment banking relationship with Bally, Boyd, Carnival, Host Hotels & Resorts, International Game Technology, LaSalle, Mariott, MGM Mirage, Pinnacle, Royal Carribean Cruise, Starwood, Sunstone, WMS Industries.
A J.P. Morgan exec it on the board of Choice Hotels International.

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET


Halftime Report

  • A Marathon gas station in Chicago.

    CNBC "Halftime Report" trader Jim Lebenthal is buying an energy stock he believes will move higher regardless of the direction of oil prices.

  • How should you China-proof your portfolio?

    Sarat Sethi, Douglas C. Lane & Associates, and the "Fast Money Halftime Report" panel discuss how to play China.

  • Top holdings in health care: Pro

    Discussing the latest pharma news making headlines including Teva's $40.5 billion deal and health care picks that show opportunity with Sam Isaly, OrbiMed Advisors founder.